Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [15137]

Novel cell-based cancer immunotherapy shows promise in early studies

Novel cell-based cancer immunotherapy shows promise in early studies

Cancer treatment with immune checkpoint inhibitors may lead to thyroid dysfunction

Cancer treatment with immune checkpoint inhibitors may lead to thyroid dysfunction

Androgen receptor stops tumor growth in the most common form of breast cancer

Androgen receptor stops tumor growth in the most common form of breast cancer

New therapeutic strategies proposed for some lung and kidney cancers

New therapeutic strategies proposed for some lung and kidney cancers

Without additional investment 11 million children are expected to die from cancer between now and 2050

Without additional investment 11 million children are expected to die from cancer between now and 2050

Oral apixaban as good as dalteparin for treating cancer-associated clots

Oral apixaban as good as dalteparin for treating cancer-associated clots

Researchers discover potential boost to immunotherapy

Researchers discover potential boost to immunotherapy

The pros and cons of radiotherapy: Will it work for you?

The pros and cons of radiotherapy: Will it work for you?

Novel therapeutic targets in cutaneous squamous cell carcinoma identified

Novel therapeutic targets in cutaneous squamous cell carcinoma identified

Researchers find way to improve cancer outcomes by examining patients' genes

Researchers find way to improve cancer outcomes by examining patients' genes

More from ecancer